The PIK3CA regulatory axis is identified as a potentially effective therapeutic strategy for lung cancer [47], considering that this signaling pathway is also targeted by other significant miRNAs, such as miR-21-5p and miR-34c (Figure 2). Here, PIK3CA is linked to lung cancer.